GI Health - Anti-Candida - Immunity
Old-Timey Doctor know-how: Our Candessence® was specially formulated to help maintain a proper balance of good bacteria and yeast in the GI Tract.* With targeted ingredients to rid the intestines of candida while adding shelf-stable probiotics and supportive prebiotics to enhance good bacteria proliferation: there's no need for super restrictive diets to rid yourself of a candida overgrowth! The addition of molybdenum helps reduce any brain fog associated with a bad yeast die-off.
Bacillus Coagulans: Also known as Lactobacillus Sporogenes and Weizmannia coagulans: is a spore-forming, "good" bacteria (probiotic) that is able to go dormant during harsh conditions allowing it to survive in an environment that may kill off other forms of probiotics. Benefits include:
Inulin: A dietary fiber, inulin is found in many fruits, vegetables and herbs. Most commonly made from soaking chicory roots in hot water. Inulin is a type of Prebiotic: meaning it stays in the bowel and acts as nourishment (food) for the "friendly" probiotic bacteria to grow and colonize.[4] It is also used to balance water content in the bowel which can help normalize both constipation and diarrhea. Additional benefits:
L. Rhamnosus: One of the most well studied "friendly or good" bacteria (probiotic) found in the intestines. May help in these situations:
Molybdenum Glycinate Chelate: A highly absorbably form of Molybdenum, it is an essential trace mineral that acts as a cofactor for enzymes involved processing proteins and in the metabolizm of sulfur-containing amino acids. Molybdenum is also involved in the process:
Potassium Bitartrate (Cream of Tartar): During the late Dr. Tommy Reavis' practice, the use of Cream of Tartar was an integral part of his program to fight candida overgrowth.* And even though it has other documented health benefits, it is from Dr. Reavis' patient successes that helped us develop this product with the inclusion of the Cream of Tartar. As Dr. Wong says: "The Cream of Tartar is a must for supporting the body in the removal of the yeast from the intestines and/or any other place it could be hiding!*"
Now to what's been documented thru science: A biproduct of wine making, it naturally has a high potassium content. The FDA has approved its use to help control pH and as an antimicrobial agent.[6].* Due to it's naturally high potassium content, cream of tartar may:
Serrapeptase: A potent enzyme, serrapeptase is included in our Candessence® to create a "clean" environment to rid the intestins of yeast so the probiotics can thrive:
Below, please find research articles and study abstracts that further detail the benefits of some of the active ingredients in Candessence®.*
These studies have been sourced and linked to from online medical research sites. If you'd like to learn more, please click HERE and search by ingredient name.
Disclaimer: This section is for educational purposes only. There is no guarantee the product will have these same benefits for everyone. Individual results may vary.*
Background: The possibility of using microbes to maintain health, and to prevent or treat disease is a topic as old as microbiology. The research of novel probiotic strains is important in order to satisfy the increasing request of the market and to obtain functional products in which the probiotic cultures are more active and with better probiotic characteristics than those already present on the market.
Aim of the study: In this study, the probiotic potential of Lactobacillus strains isolated from Italian elderly human faeces was investigated.
Methods: The Lactobacillus strains were identified and examined for resistance to gastric acidity and bile toxicity, adhesion to HT-29 cells, antimicrobial activities, antibiotic susceptibility and plasmid profile. Survival of the strains through human intestine was examined in a 3 months human feeding trial.
Results: Two strains, Lactobacillus rhamnosus IMC 501 and Lactobacillus paracasei IMC 502, tolerated well low pH and bile acids. In antimicrobial activity assays, both strains showed inhibitory properties towards selected potential harmful microorganisms, particularly against Candida albicans. The two selected strains expressed high in vitro adherence to HT-29 cells increasing this characteristic when they are used in combination and they were resistant to vamcomycin, colistin sulphate, gentamicin, oxolinic acid and kanamycin. Moreover, the two strains could be recovered from stools of volunteers after the feeding trials.
Conclusions: Lactobacillus rhamnosus IMC 501 and L. paracasei IMC 502 present favourable strain-specific properties for their utilisation as probiotics in functional foods and the high adhesion ability of the L. rhamnosus IMC 501 and L. paracasei IMC 502 used in combination, confirmed by both in vitro and in vivo study, indicate that the two bacterial strains could be used as health-promoting bacteria.
A number of clinical studies have shown protective effects of lactobacilli against Candida species in the gastrointestinal tract, the urogenital tract and the oral cavity, while others did not show clear effects. Evidence on the mode of action of lactobacilli against Candida is also still lacking. In this study, the anti‐Candida activity of the model probiotic strain Lactobacillus rhamnosus GG was explored in different assays to determine molecular interactions. We found that L. rhamnosus GG was able to interfere with Candida growth, morphogenesis and adhesion. These three aspects of Candida's physiology are all crucial to its opportunistic pathogenesis. In follow‐up assays, we compared the activity of L. rhamnosus GG wild‐type with its exopolysaccharide (EPS)‐deficient mutant and purified EPS to evaluate the involvement of this outer carbohydrate layer. Our data demonstrate that purified EPS can both interfere with hyphal formation and adhesion to epithelial cells, which indicates that EPS is part of a combined molecular mechanism underlying the antihyphal and anti‐adhesion mechanisms of L. rhamnosus GG.
Background: There is great interest in the search for new alternatives to antimicrobial drugs, and the use of synbiotics is a promising approach to this problem. This study evaluated the growth inhibition and antibiofilm activity of the short-chain fatty acids produced by Lacticaseibacillus rhamnosus and Pediococcus acidilactici in combination with inulin-type fructans against Candida albicans. Methods: The growth inhibition of Candida was evaluated using microdilution analysis in 96-well microtiter plates; different concentrations of cell-free supernatants of Lacticaseibacillus rhamnosus and Pediococcus acidilactici were exposed to Candida albicans. The antibiofilm assessment was carried out using the crystal violet staining assay. The short-chain fatty acids were analyzed by gas chromatography. Results: The clinically isolated Candida albicans interacted with supernatants from Lacticaseibacillus rhamnosus and Pediococcus acidilactici and showed significant growth inhibition and antibiofilm formation versus the controls. Lactate and acetic acid were elevated in the supernatants. The results suggest that the supernatants obtained from the synbiotic combinations of Lacticaseibacillus rhamnosus and Pediococcus acidilactici with inulin-type fructans can inhibit the growth and biofilm formation against a clinically isolated Candida albicans strain. Conclusions: These results suggest that synbiotic formulations could be a promising alternative to antifungal drugs in candidiasis therapy.
Aim. To evaluate the effectiveness of inulin for the adjustment of intestinal microflora in patients with recurrent vulvovaginal candidiasis (VVC). Materials and methods. A prospective cohort comparative study included 79 women aged 18 to 50 years. They were divided into three groups: the main group included 32 patients receiving complex treatment with a dietary supplement containing inulin derived from the "Extra" variety of Jerusalem artichoke root in combination with fluconazole; the comparison group included 27 patients receiving fluconazole only; and the control group included 20 healthy women. The patients were followed up for 12 months. Examination included stool culture for dysbiosis, complete blood count, urinalysis, blood chemistry (glucose, bilirubin, alanine aminotransferase, aspartate aminotransferase, total protein, urea, creatinine), examination of the vulva and vaginal mucosa, vaginal smear microscopy for microflora, Gram staining, real-time polymerase chain reaction for Mycoplasma hominis, Ureaplasma parvum, Trihomonas vaginalis, Chlamydia traсhomatis, Candida albicans. Subsequently, all subjects every three months underwent a bimanual examination, speculum examination of the cervical mucosa and vagina, Gram staining of vaginal mucosa and cervix swabs, a thorough interview, and history taking. At 12 months, stool was cultured for dysbiosis again, and the data were analyzed. Results. The VVC therapy in the group of inulin-containing dietary supplement was more effective: the recurrence rate was 3 times lower than with the standard treatment regimen. Conclusion. The use of dietary supplement containing inulin derived from the "Extra" variety of Jerusalem artichoke root in complex therapy for recurrent VVC can significantly improve the gut and vagina microflora condition and prevent the recurrence and normalization of stool in patients.
Probiotics are living microbes that provide benefits to the host. The growing data on health promotion, following probiotics administration, increased interest among researchers and pharmaceutical companies. Infections of the lower genital tract in females, caused by a wide range of pathogens, represent one of the main areas for the use of probiotics and postbiotics. Vulvovaginal candidiasis (VVC) affects 75% of women of reproductive age at least once during their lifetime, with 5–8% developing the recurrent form (RVVC). The disease is triggered by the overgrowth of Candida on the vaginal mucosa. Here, in order to establish its probiotic potential in the context of VVC, we evaluated the anti-fungal effects of the spore-producing Bacillus coagulans LMG S-24828 against C. albicans and C. parapsilosis as well as its beneficial effects in counteracting Candida vaginal infection in vitro. Our results show that both live B. coagulans and its Cell-Free Supernatant (CFS) exerted antifungal activity against both fungi. Moreover, live B. coagulans reduced hyphal formation, inhibited C. albicans adhesion to vaginal epithelial cells, showed co-aggregation capacity, and exerted a protective effect on vaginal epithelial cells infected with C. albicans. These data suggest that B. coagulans LMG S-24828 may provide benefits in the context of Candida vaginal infections.
Office Hours:
When We Ship:
How We Ship
Within the USA:
International Shipping:
You may return most new, unopened items within 30 days of delivery for a refund of the purchase price less a 15% restocking fee and any shipping charges. The return item(s) must be in their original condition (unopened and unused) and accompanied by a copy of the original order form/packing list.
For health and safety reasons, we are unable to accept returns of personal care items such as lotions or creams.
No returns or refunds on unsealed (ie: opened) items, creams and books. No exceptions!
If you need to return an item, please contact us with your order number and details about the product you would like to return. We will respond quickly with a Return Authorization (RA) number and instructions for how to return the items. Returned items without a RA number will not be processed.
Items can be returned via any carrier you choose. We recommend you send the items insured, signature required.
Please mail to:
WAM Essentials, Inc; 320 Grant Ave; Strawn; TX 76475
Please see below for answers to some commonly asked questions.
In the event that you receive your package and it is missing an item or includes an incorrect item, we must be contacted within three (3) business days of receipt of the package for resolution/ answers. No refund/return can be issued if more than three (3) business days pass without an attempt to contact us.
If you have a questions about packing (ie: safety seals, mfg vs expiration dates, lid liners, etc), we must be contacted within three (3) business days of receipt of the package for resolution/ answers. No refund/return can be issued if more than three (3) business days pass without an attempt to contact us.
Please see below for the most commonly asked questions about Candessence®. We will continually add more FAQs to this as more questions come in to us.
No, the Candessence® can be taken with food and with other nutritional supplements.
You can take the Candessence® supplement whenever it is convenient for you.
We've formulated the Candessence® to be a stand alone anti-candida GI supportive product. There are already two probiotics as well as prebiotics in the blend. However, it is perfectly okay to also take your favorite probiotic product to further enhance good bacteria colonization and proliferation in your GI tract.
